Current therapies for cardiac allograft vasculopathy in children.

about

Adult and pediatric perspectives on heart retransplant.Tmem time: memory T-cells in cardiac allograft vasculopathy : editorial to: "memory t cells mediate cardiac allograft vasculopathy and are inactivated by anti-OX40L monoclonal antibody" by Hao Wang et al.

P2860

Q38116951-DCCA250E-0AF6-47C7-B46F-96908295B314 Q42409883-35E994DF-D230-420F-AA93-3BA77077C476

P2860

Current therapies for cardiac allograft vasculopathy in children.

Item

http://www.wikidata.org/entity/Q38011870

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Current therapies for cardiac allograft vasculopathy in children.

@en

type

Item

label

Current therapies for cardiac allograft vasculopathy in children.

@en

prefLabel

Current therapies for cardiac allograft vasculopathy in children.

@en

P1476

Current therapies for cardiac allograft vasculopathy in children.

@en

P2093

Elfriede Pahl

http://www.w3.org/2001/XMLSchema#string

Steven J Kindel

http://www.w3.org/2001/XMLSchema#string

P2860

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Effect of oral L-arginine on oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients.

Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing.

Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.

Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation.

The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.

Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators.

Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.

Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.

P304

324-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1747-0803.2012.00666.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22613206

http://www.w3.org/2001/XMLSchema#string

Current therapies for cardiac allograft vasculopathy in children.

about

P2860

P2860

Current therapies for cardiac allograft vasculopathy in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698